Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 423
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01655745 | Positron Emission Tomography (PET) Study for Staging of Muscle Invasive Bladder Cancer | ||
| NCT07588607 | Social Media Posts About Cancer: Five Timepoints | ||
| NCT05985538 | Impact of E-Cigarette Prevention Messages on Adolescents | ||
| NCT01726738 | LCCC 1128: Open Label Phase II Trial of the BRAF Inhibitor (Dabrafenib) and the MEK Inhibitor (Trametinib) in Unresectable Stage III and Stage IV BRAF Mutant Melanoma; Correlation of Resistance With the Kinome and Functional Mutations | ||
| NCT07389967 | Nutrition Awareness Among Women With Non-Metastatic Breast Cancer | ||
| NCT02281955 | De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study | ||
| NCT00998101 | Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With Chemotherapy | ||
| NCT03820024 | MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback | ||
| NCT07553520 | Dietary Cysteine and Methionine Deprivation (CMD) in Glioma Patients | ||
| NCT07599462 | Pilot Study of Communication for Dual Users of Cigarettes and E-cigarettes | ||
| NCT01492881 | Study of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma | ||
| NCT02768792 | High Dose Cytarabine Followed by Pembrolizumab in Relapsed/Refractory AML | ||
| NCT01752751 | Predicting Tolerance to Radiation Therapy in Older Adults With Cancer | ||
| NCT00499395 | Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer | ||
| NCT04432753 | Effect of Incidental Findings Information on Lung Cancer Screening Intent | ||
| NCT05440929 | Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians | ||
| NCT07605949 | Revumenib, Azacitidine, and VENetoclax in Newly Diagnosed KMT2A-Rearranged AML | ||
| NCT00280176 | Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer | ||
| NCT00489216 | Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids | ||
| NCT03977233 | Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer | ||
| NCT05754749 | Comparison of CE-DBT and MRI in Patients With Known Breast Lesions | ||
| NCT03446157 | Palbociclib and Cetuximab in Metastatic Colorectal Cancer | ||
| NCT01751516 | PET/MRI as a Predictor of Response to Pre-op Chemoradiation in Resectable Rectal Cancer: a Pilot Study | ||
| NCT03160209 | HIV and Other Risk Factors for Esophageal Squamous Cell Carcinoma in Malawi | ||
| NCT05472792 | Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy | ||
| NCT04492007 | Feasibility Testing of Patient Reported Outcomes - Informed Symptom Management System (PRISMS) | ||
| NCT05630131 | ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy | ||
| NCT03620019 | Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma | ||
| NCT01412229 | Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck | ||
| NCT05978570 | Physical Therapy in Pre-cystectomy Patients | ||
| NCT01169012 | PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias | ||
| NCT00005827 | Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer | ||
| NCT00006108 | Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer | ||
| NCT06618274 | Effectiveness of Central Oncology Navigation and the Use of an ORN | ||
| NCT03769415 | Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA | ||
| NCT00266097 | Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer | ||
| NCT02449837 | Investigation of Circulating Tumor Cells From Cancer Patients Undergoing Radiation Therapy | ||
| NCT00312637 | Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of Disease | ||
| NCT03488862 | Pilot Evaluation of a Microfluidic Assay to Detect Minimal Residual Disease and Predict Relapse in AML Patients | ||
| NCT04350788 | Enhancing Survivorship Care Planning for Patients With Localized Prostate Cancer Using A Couple-focused Web-based Tailored Symptom Self-management Program | ||
| NCT04504201 | Patient-centered Communication About Healthy Weight in Early Breast Cancer | ||
| NCT05366166 | Pembrolizumab Plus Olaparib in LA-HNSCC | ||
| NCT04142554 | Parsaclisib in Newly Diagnosed Stage I-IIIC Triple Negative or HER2+ Breast Cancer | ||
| NCT07278557 | Sparing Parotid Ducts Via MRI Sialography for Reduced Patient-Reported Xerostomia | ||
| NCT03885830 | Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients | ||
| NCT05574478 | Metastatic Breast Cancer-Specific Prognostic Tool | ||
| NCT01859858 | Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors | ||
| NCT01702844 | Single Arm on the Tolerability of Weekly Nab-paclitaxel | ||
| NCT04223765 | Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. | ||
| NCT05751993 | Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions |
